Inmune Bio (INMB) Accumulated Expenses (2022 - 2024)
Historic Accumulated Expenses for Inmune Bio (INMB) over the last 3 years, with Q2 2024 value amounting to $139000.0.
- Inmune Bio's Accumulated Expenses rose 144444.44% to $139000.0 in Q2 2024 from the same period last year, while for Jun 2024 it was $139000.0, marking a year-over-year increase of 144444.44%. This contributed to the annual value of $35000.0 for FY2023, which is 28888.89% up from last year.
- Per Inmune Bio's latest filing, its Accumulated Expenses stood at $139000.0 for Q2 2024, which was up 144444.44% from $56000.0 recorded in Q1 2024.
- Over the past 5 years, Inmune Bio's Accumulated Expenses peaked at $139000.0 during Q2 2024, and registered a low of $9000.0 during Q4 2022.
- In the last 3 years, Inmune Bio's Accumulated Expenses had a median value of $35000.0 in 2023 and averaged $48000.0.
- As far as peak fluctuations go, Inmune Bio's Accumulated Expenses soared by 28888.89% in 2023, and later soared by 144444.44% in 2024.
- Over the past 3 years, Inmune Bio's Accumulated Expenses (Quarter) stood at $9000.0 in 2022, then skyrocketed by 288.89% to $35000.0 in 2023, then skyrocketed by 297.14% to $139000.0 in 2024.
- Its Accumulated Expenses stands at $139000.0 for Q2 2024, versus $56000.0 for Q1 2024 and $35000.0 for Q4 2023.